Abstract
We review the role of two susceptibility genes; G72 and DAAO in glutamate neurotransmission and the aetiology of schizophrenia. The gene product of G72 is an activator of DAAO (D-amino acid oxidase), which is the only enzyme oxidising D-serine. D-serine is an important co-agonist for the NMDA glutamate receptor and plays a role in neuronal migration and cell death. Studies of D-serine revealed lower serum levels in schizophrenia patients as compared to healthy controls. Furthermore, administration of D-serine as add-on medication reduced the symptoms of schizophrenia. The underlying mechanism of the involvement of G72 and DAAO in schizophrenia is probably based on decreased levels of D-serine and decreased NMDA receptor functioning in patients. The involvement of this gene is therefore indirect support for the glutamate dysfunction hypothesis in schizophrenia.
Original language | English |
---|---|
Pages (from-to) | 567-72 |
Number of pages | 6 |
Journal | European Neuropsychopharmacology |
Volume | 17 |
Issue number | 9 |
DOIs | |
Publication status | Published - Sep-2007 |
Externally published | Yes |
Keywords
- Carrier Proteins
- D-Amino-Acid Oxidase
- Genetic Predisposition to Disease
- Glutamic Acid
- Humans
- Models, Biological
- Schizophrenia
- Synaptic Transmission
- Journal Article
- Review